Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma
Clinical trial NCT03782415 · COMPLETED
Trial details
- NCT number
- NCT03782415
- Sponsor
- MediciNova
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-29
- Primary completion
- 2023-08-07
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.